NASDAQ NMS - GLOBAL MARKET · AYTU
-0.56% · -$0.0123 · Vol 11.8K
Live · updated 12:37:08 ET
Aytu Biopharma Inc

Aytu Biopharma Inc

Pharmaceuticals
$2.17
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is AYTU moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Aytu Biopharma Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2008
Employees
83
Country
US

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.20
Day high
$2.22
Day low
$2.16
Previous close
$2.18
52W high
$2.31
-6.16% from high
52W low
$2.08
38% of range
Market cap
$23.4M
EPS
$-1.4500
Shares out
10.7M
Volume
11.8K
VWAP
$2.19
Price history computed in-house
1W
+0.36%
1M
-3.23%
SMA 50 $2.19 · below
SMA 200 $2.19 · below
52W position 38%
Veridion warehouse edge

Warehouse intelligence for AYTU.

Veridion Score
54
0: 951: 522: 393: 204: 785: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

AYTU insider activity

Aytu Biopharma Inc

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for AYTU.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

AYTU contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for AYTU in this window.
Lobbying spend

AYTU lobbying filings, year to date.

Registered lobbying filings matched to Aytu Biopharma Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for AYTU in this window.
Latest news · AYTU
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for AYTU.
Options
Sovereign unlock shows live options positioning for AYTU.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.